Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Online ACT for Disorders of Gut-Brain Interaction: See if it helps you cope

Official title: Efficacy, and Cost-effectiveness of an Online ACT Intervention for Disorders of Gut-Brain Interaction (iACTforDGBI)

Run by Örebro University, Sweden · NCT07814196 · Data updated 2026-11-12

This online program tests whether the iACTforDGBI program helps people with gut-brain disorders who are feeling distress, compared with an active control called DGBI School.

More Psychological Distress trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment200 (estimated)
SponsorÖrebro University, Sweden
Academic / other
Locations1 site (Örebro)
StatusRecruiting
StartedSeptember 15, 2026
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedOctober 23, 2026
Trial IDNCT07814196 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–75 with at least one DGBI diagnosis and stable psychiatric symptoms who can read Swedish and access internet-enabled devices for video sessions.

Probably not a fit

Individuals without DGBI symptoms, with unstable psychiatric treatment, or without reliable internet access may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares an online ACT-based program for disorders of gut-brain interaction with an active control. Adults aged 18 to 75 with at least one DGBI diagnosis and stable psychiatric medication participate in a randomized or controlled design to test efficacy and cost-effectiveness. Participants must have internet access, be able to read Swedish, and can attend video sessions. Exclusions include active psychological treatment for other conditions, high suicide risk, or certain severe psychiatric disorders. The primary aim is to determine whether iACTforDGBI improves symptoms and is cost-effective relative to the DGBI School program.

Why it matters

Potential benefit: If successful, participants may experience improved GI-related symptoms and distress, with evidence on whether the online program provides good value for care.

How similar studies have gone: Previous ACT-based approaches for functional GI disorders have shown promising results, though online delivery and cost-effectiveness data in this specific DGBI population are still being established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 75 years
* Meeting clinical symptom levels for least one DGBI diagnosis (assessed with the Rome IV Diagnostic Questionnaire for Functional Gastrointestinal Disorders in Adults (Palsson et al., 2016))
* Stable medication for psychiatric symptoms including anxiety, depression and sleep problems for at least two months prior to intervention.
* Ability to read and write Swedish
* Have access to a device (like computer, tablet or smartphone with) with access to the internet and that can be used to attend video conferences and preview the intervention platform (i.e., have a microphone and speakers or headphones).

Exclusion Criteria:

* Currently undergoing any form of psychological intervention.
* Increased risk of suicide (≥4 points on MADRS item 9).
* Ongoing or previously diagnosed severe psychiatric disorder, such as schizophrenia spectrum disorders or bipolar disorder.

Where it's running

  • Örebro University
    Örebro, Sweden
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.